{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T14:39:42Z","timestamp":1790260782962,"version":"4.1.0"},"reference-count":102,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","seminarsinnephrology.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Nephrology"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.semnephrol.2017.05.020","type":"journal-article","created":{"date-parts":[[2017,8,29]],"date-time":"2017-08-29T08:15:16Z","timestamp":1503994516000},"page":"478-487","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Immunoadsorption in Autoimmune Diseases Affecting the Kidney"],"prefix":"10.1016","volume":"37","author":[{"given":"Georg","family":"Stummvoll","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Aringer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ammon","family":"Handisurya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt","family":"Derfler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semnephrol.2017.05.020_bib1","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3109\/08916934.2010.541170","article-title":"Nephritogenic antibodies bind in glomeruli through interaction with exposed chromatin fragments and not with renal cross-reactive antigens","volume":"44","author":"Mjelle","year":"2011","journal-title":"Autoimmunity"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib2","first-page":"1495","article-title":"Multiple autoantibodies form the glomerular immune deposits in patients with systemic lupus erythematosus","volume":"30","author":"Mannik","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib3","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1182\/blood-2005-03-0921","article-title":"Antineutrophil cytoplasm antibodies directed against myeloperoxidase augment leukocyte-microvascular interactions in vivo","volume":"106","author":"Little","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib4","first-page":"727","article-title":"Anti-glomerular basement membrane antibodies","volume":"16","author":"Silvarino","year":"2014","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib5","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1002\/art.1780340803","article-title":"Long-term preservation of renal function in patients with lupus nephritis receiving treatment that includes cyclophosphamide versus those treated with prednisone only","volume":"34","author":"Steinberg","year":"1991","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib6","doi-asserted-by":"crossref","first-page":"76","DOI":"10.7326\/0003-4819-98-1-76","article-title":"Wegener\u2019s granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years","volume":"98","author":"Fauci","year":"1983","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib7","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1186\/ar2780","article-title":"B cells in autoimmunity","volume":"11","author":"Dorner","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib8","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s13075-015-0603-8","article-title":"Differential effects of cyclophosphamide and mycophenolate mofetil on cellular and serological parameters in patients with systemic lupus erythematosus","volume":"17","author":"Fassbinder","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib9","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jaut.2012.05.010","article-title":"Bone marrow of NZB\/W mice is the major site for plasma cells resistant to dexamethasone and cyclophosphamide: implications for the treatment of autoimmunity","volume":"39","author":"Mumtaz","year":"2012","journal-title":"J Autoimmun"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib10","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0140-6736(10)61354-2","article-title":"Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial","volume":"377","author":"Navarra","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib11","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1093\/ndt\/gfs285","article-title":"Beyond the LUNAR trial. Efficacy of rituximab in refractory lupus nephritis","volume":"28","author":"Weidenbusch","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib12","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s40620-014-0135-3","article-title":"Current therapy of granulomatosis with polyangiitis and microscopic polyangiitis: the role of rituximab","volume":"28","author":"Geetha","year":"2015","journal-title":"J Nephrol"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib13","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/RHU.0000000000000291","article-title":"systematic review of diffuse alveolar hemorrhage in systemic lupus erythematosus: focus on outcome and therapy","volume":"21","author":"Ednalino","year":"2015","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib14","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1177\/0961203309104860","article-title":"Dyspnoea in a young woman with active systemic lupus erythematosus","volume":"18","author":"Todd","year":"2009","journal-title":"Lupus"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib15","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/S0761-8425(08)75093-9","article-title":"[Respiratory involvement in systemic lupus erythematosus]","volume":"25","author":"Carmier","year":"2008","journal-title":"Rev Mal Respir"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib16","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/BOR.0b013e32834120c1","article-title":"Plasma exchange in the treatment of Wegener\u2019s granulomatosis, microscopic polyangiitis, Churg-Strauss syndrome and renal limited vasculitis","volume":"23","author":"Casian","year":"2011","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib17","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.kint.2016.06.009","article-title":"Plasmapheresis for the treatment of kidney diseases","volume":"90","author":"Clark","year":"2016","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib18","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/jca.2920070314","article-title":"Plasmapheresis therapy is ineffective in SLE. Lupus Nephritis Collaborative Study Group","volume":"7","author":"Lewis","year":"1992","journal-title":"J Clin Apheresis"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib19","first-page":"307","article-title":"Therapy of lupus nephritis. A two-year prospective study","volume":"145","author":"Doria","year":"1994","journal-title":"Ann Med Interne (Paris)"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib20","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/1529-0131(199803)41:3<414::AID-ART6>3.0.CO;2-N","article-title":"Severe infections in plasmapheresis-treated systemic lupus erythematosus","volume":"41","author":"Aringer","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib21","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.autrev.2015.08.010","article-title":"Efficacy of plasma exchange and immunoadsorption in systemic lupus erythematosus and antiphospholipid syndrome: a systematic review","volume":"15","author":"Kronbichler","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib22","first-page":"S61","article-title":"Plasmapheresis and immunoadsorption: different techniques and their current role in medical therapy","volume":"64","author":"Schneider","year":"1998","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib23","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/00002480-199743010-00010","article-title":"Efficacy and safety of immunoglobulin apheresis","volume":"43","author":"Richter","year":"1997","journal-title":"ASAIO J"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib24","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1053\/ajkd.2002.30564","article-title":"Treatment of systemic lupus erythematosus by immunoadsorption in a patient suffering from tuberculosis","volume":"39","author":"Schmaldienst","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib25","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1007\/s00508-004-0232-8","article-title":"Immunoadsorption (IAS) as a rescue therapy in SLE: considerations on safety and efficacy","volume":"116","author":"Stummvoll","year":"2004","journal-title":"Wien Klin Wochenschr"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib26","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1093\/ndt\/gfr239","article-title":"Lupus nephritis: prolonged immunoadsorption (IAS) reduces proteinuria and stabilizes global disease activity","volume":"27","author":"Stummvoll","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib27","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1159\/000066343","article-title":"Immunoadsorption and plasma exchange in pregnancy","volume":"25","author":"Dittrich","year":"2002","journal-title":"Kidney Blood Press Res"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib28","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1053\/j.ajkd.2005.05.023","article-title":"The course of anticardiolipin antibody levels under immunoadsorption therapy","volume":"46","author":"Hauser","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib29","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1177\/0961203310389487","article-title":"Immunoadsorption (IAS) for systemic lupus erythematosus","volume":"20","author":"Stummvoll","year":"2011","journal-title":"Lupus"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib30","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/jca.21399","article-title":"Effect of combined treatment with immunoadsorption and membrane filtration on plasma coagulation--results of a randomized controlled crossover study","volume":"31","author":"Biesenbach","year":"2016","journal-title":"J Clin Apher"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib31","first-page":"603","article-title":"Special focus--antibody-mediated rejection. Guest editorial","volume":"25","author":"Bohmig","year":"2012","journal-title":"Transpl Int"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib32","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1600-6143.2006.01613.x","article-title":"Immunoadsorption in severe C4d-positive acute kidney allograft rejection: a randomized controlled trial","volume":"7","author":"Bohmig","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib33","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1093\/ndt\/gft502","article-title":"ABO antibody and complement depletion by immunoadsorption combined with membrane filtration--a randomized, controlled, cross-over trial","volume":"29","author":"Eskandary","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib34","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00508-009-1161-3","article-title":"Vienna experience of ABO-incompatible living-donor kidney transplantation","volume":"121","author":"Haidinger","year":"2009","journal-title":"Wien Klin Wochenschr"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib35","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1093\/ndt\/gfr610","article-title":"Anti-A\/B antibody depletion by semiselective versus ABO blood group-specific immunoadsorption","volume":"27","author":"Wahrmann","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib36","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.humimm.2016.05.021","article-title":"Pathogenesis of non-HLA antibodies in solid organ transplantation: where do we stand?","volume":"77","author":"Delville","year":"2016","journal-title":"Hum Immunol"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib37","series-title":"Systemic lupus erythematosus","first-page":"214","article-title":"Immune complexes in systemic lupus erythematosus","author":"Wener","year":"2007"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib38","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.1002\/art.20628","article-title":"The American College of Rheumatology response criteria for systemic lupus erythematosus clinical trials: measures of overall disease activity","volume":"50","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib39","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3109\/08830188909086990","article-title":"Pathogenic subsets of antibodies to DNA","volume":"5","author":"Ebling","year":"1989","journal-title":"Int Rev Immunol"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib40","first-page":"345","article-title":"Lupus nephritis: the significance of serological tests at the time of biopsy","volume":"9","author":"Houssiau","year":"1991","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib41","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/art.1780220808","article-title":"Deposition of antibodies to a soluble cytoplasmic antigen in the kidneys of patients with systemic lupus erythematosus","volume":"22","author":"Maddison","year":"1979","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib42","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1093\/intimm\/6.6.817","article-title":"Comparison of pathogenic and non-pathogenic murine antibodies to DNA: antigen binding and structural characteristics","volume":"6","author":"Ohnishi","year":"1994","journal-title":"Int Immunol"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib43","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.4049\/jimmunol.142.9.3076","article-title":"Anti-DNA antibodies bind directly to renal antigens and induce kidney dysfunction in the isolated perfused rat kidney","volume":"142","author":"Raz","year":"1989","journal-title":"J Immunol"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib44","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.4049\/jimmunol.138.9.2883","article-title":"Murine monoclonal anti-DNA antibodies bind directly to glomerular antigens and form immune deposits","volume":"138","author":"Madaio","year":"1987","journal-title":"J Immunol"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib45","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1136\/ard.2004.029660","article-title":"IgG immunoadsorption reduces systemic lupus erythematosus activity and proteinuria: a long term observational study","volume":"64","author":"Stummvoll","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib46","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1006\/jaut.1998.0229","article-title":"Prospective randomized trial of two different immunoadsorbers in severe systemic lupus erythematosus","volume":"11","author":"Gaubitz","year":"1998","journal-title":"J Autoimmun"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib47","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S1567-5688(09)71824-0","article-title":"Immunoadsorption in SLE: three different high affinity columns are adequately effective in removing autoantibodies and controlling disease activity","volume":"10","author":"Biesenbach","year":"2009","journal-title":"Artherosclerosos Suppl"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib48","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1046\/j.1526-0968.2001.00370.x","article-title":"Background and indications for protein A-based extracorporeal immunoadsorption","volume":"5","author":"Matic","year":"2001","journal-title":"Ther Apher"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib49","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/0006-291X(80)91255-3","article-title":"Immune complex formation enhances the binding of staphylococcal protein A to immunoglobulin G","volume":"94","author":"Langone","year":"1980","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib50","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1046\/j.1526-0968.2003.00017.x","article-title":"Peptide based adsorbers for therapeutic immunoadsorption","volume":"7","author":"Ronspeck","year":"2003","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib51","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1744-9987.1998.tb00093.x","article-title":"Ig-Therasorb immunoadsorption for selective removal of human immunoglobulins in diseases associated with pathogenic antibodies of all classes and IgG subclasses, immune complexes, and fragments of immunoglobulins","volume":"2","author":"Koll","year":"1998","journal-title":"Ther Apher"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib52","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1091-6660.1999.t01-2-.x","article-title":"C1q: a multifunctional ligand for a new immunoadsorption treatment","volume":"3","author":"Hiepe","year":"1999","journal-title":"Ther Apher"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib53","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1002\/1529-0131(200108)44:8<1962::AID-ART335>3.0.CO;2-R","article-title":"Successful treatment of patients with systemic lupus erythematosus by immunoadsorption with a C1q column: a pilot study","volume":"44","author":"Pfueller","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib54","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s12026-013-8412-0","article-title":"Extracorporeal immunoadsorption of antibodies against the VRT-101 laminin epitope in systemic lupus erythematosus: a feasibility evaluation study","volume":"56","author":"Hershko","year":"2013","journal-title":"Immunol Res"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib55","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/BF01910319","article-title":"Rapid elimination of a high-titer spontaneous factor V antibody by extracorporeal antibody-based immunoadsorption and immunosuppression","volume":"71","author":"Tribl","year":"1995","journal-title":"Ann Hematol"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib56","doi-asserted-by":"crossref","first-page":"e103568","DOI":"10.1371\/journal.pone.0103568","article-title":"Long-term outcome of anti-glomerular basement membrane antibody disease treated with immunoadsorption","volume":"9","author":"Biesenbach","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib57","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1055\/s-0038-1649876","article-title":"Elimination of acquired factor VIII antibodies by extracorporal antibody-based immunoadsorption (Ig-Therasorb)","volume":"74","author":"Knobl","year":"1995","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib58","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/rheumatology\/40.5.513","article-title":"Intravenous immunoglobulin application following immunoadsorption: benefit or risk in patients with autoimmune diseases?","volume":"40","author":"Schmaldienst","year":"2001","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib59","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/ndt\/15.9.1367","article-title":"Immunoadsorption onto protein A induces remission in severe systemic lupus erythematosus","volume":"15","author":"Braun","year":"2000","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib60","first-page":"323","article-title":"Concomitant reduction of disease activity and IL-10 secreting peripheral blood mononuclear cells during immunoadsorption in patients with active systemic lupus erythematosus","volume":"48","author":"Willeke","year":"2002","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib61","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1046\/j.1526-0968.2000.00178.x","article-title":"The role of immunoadsorption using dextran-sulfate cellulose columns in the treatment of systemic lupus erythematosus","volume":"4","author":"Suzuki","year":"2000","journal-title":"Ther Apher"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib62","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1002\/art.39026","article-title":"Predictors of long-term renal outcome in lupus nephritis trials: lessons learned from the Euro-Lupus Nephritis cohort","volume":"67","author":"Dall\u2019Era","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib63","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1002\/art.1780341211","article-title":"Continuous removal of anti-DNA antibody, using a new extracorporeal immunoadsorption system, in patients with systemic lupus erythematosus","volume":"34","author":"Suzuki","year":"1991","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib64","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1744-9987.2006.00362.x","article-title":"Immunoadsorption plasmapheresis using a phenylalanine column as an effective treatment for lupus nephritis","volume":"10","author":"Sugimoto","year":"2006","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib65","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.transci.2010.10.003","article-title":"Immunoadsorption and plasmapheresis are equally efficacious as adjunctive therapies for severe lupus nephritis","volume":"43","author":"Loo","year":"2010","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib66","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/art.34359","article-title":"Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the Lupus Nephritis Assessment with Rituximab study","volume":"64","author":"Rovin","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib67","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1136\/ard.2006.054593","article-title":"Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies","volume":"66","author":"Watts","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib68","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s11926-005-0036-5","article-title":"Epidemiology of systemic vasculitis","volume":"7","author":"Lane","year":"2005","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib69","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1053\/j.ajkd.2010.10.049","article-title":"Plasma exchange for renal vasculitis and idiopathic rapidly progressive glomerulonephritis: a meta-analysis","volume":"57","author":"Walsh","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib70","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1136\/annrheumdis-2016-209133","article-title":"EULAR\/ERA-EDTA recommendations for the management of ANCA-associated vasculitis","volume":"75","author":"Yates","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib71","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1745-6215-14-73","article-title":"Plasma exchange and glucocorticoid dosing in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis (PEXIVAS): protocol for a randomized controlled trial","volume":"14","author":"Walsh","year":"2013","journal-title":"Trials"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib72","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1159\/000187471","article-title":"Influence of immunoadsorption on the removal of immunoglobulin G autoantibodies in crescentic glomerulonephritis","volume":"65","author":"Esnault","year":"1993","journal-title":"Nephron"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib73","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1681\/ASN.V641178","article-title":"Identification of the alpha 3 chain of type IV collagen as the common autoantigen in antibasement membrane disease and Goodpasture syndrome","volume":"6","author":"Kalluri","year":"1995","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib74","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/00005792-198507000-00003","article-title":"Therapy of anti-glomerular basement membrane antibody disease: analysis of prognostic significance of clinical, pathologic and treatment factors","volume":"64","author":"Johnson","year":"1985","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib75","first-page":"312","article-title":"Staphylococcal protein A immunoadsorption for Goodpasture\u2019s syndrome in four Chinese patients","volume":"19","author":"Hu","year":"2006","journal-title":"J Nephrol"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib76","first-page":"59","article-title":"[Therapeutic immunoadsorption in Goodpasture disease]","volume":"105","author":"Moreso","year":"1995","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib77","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1053\/ajkd.2000.8993","article-title":"Immunoadsorption in Goodpasture\u2019s syndrome","volume":"36","author":"Laczika","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib78","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/eci.12410","article-title":"Frequency, risk factors and prophylaxis of infection in ANCA-associated vasculitis","volume":"45","author":"Kronbichler","year":"2015","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib79","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/1744-9987.12474","article-title":"Therapeutic apheresis in hematologic, autoimmune and dermatologic diseases with immunologic origin","volume":"20","author":"Bambauer","year":"2016","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib80","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1744-9987.2012.01075.x","article-title":"Immunoadsorption in dermatology","volume":"16","author":"Meyersburg","year":"2012","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib81","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s00403-009-1024-9","article-title":"Immunoadsorption in dermatology","volume":"302","author":"Schmidt","year":"2010","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib82","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/jca.21266","article-title":"Therapeutic plasma exchange in neurology: 2012","volume":"28","author":"Cortese","year":"2013","journal-title":"J Clin Apher"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib83","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.atherosclerosissup.2012.10.026","article-title":"Immunoadsorption in steroid-refractory multiple sclerosis","volume":"14","author":"Koziolek","year":"2013","journal-title":"Atheroscler Suppl"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib84","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1016\/j.clinre.2015.04.003","article-title":"Treatment of severe refractory de novo auto-immune hepatitis after liver transplantation with plasmapheresis","volume":"39","author":"Dumortier","year":"2015","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib85","first-page":"706","article-title":"Plasmapheresis, intravenous immunoglobulins and betamethasone - a combined protocol to treat autoimmune congenital heart block: a prospective cohort study","volume":"34","author":"Ruffatti","year":"2016","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib86","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/tme.12103","article-title":"The use of therapeutic apheresis in cardiovascular disease","volume":"24","author":"Pignalosa","year":"2014","journal-title":"Transfus Med"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib87","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/jca.21245","article-title":"Apheresis in the treatment of idiopathic dilated cardiomyopathy","volume":"27","author":"Winters","year":"2012","journal-title":"J Clin Apher"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib88","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/jca.21370","article-title":"Role of therapeutic apheresis in infectious and inflammatory diseases: current knowledge and unanswered questions","volume":"30","author":"Sloan","year":"2015","journal-title":"J Clin Apher"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib89","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.transci.2015.11.006","article-title":"Apheresis in high risk antiphospholipid syndrome pregnancy and autoimmune congenital heart block","volume":"53","author":"Ruffatti","year":"2015","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib90","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.atherosclerosissup.2012.10.034","article-title":"Immunoadsorption for connective tissue disease","volume":"14","author":"Hohenstein","year":"2013","journal-title":"Atheroscler Suppl"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib91","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1440-1843.2012.02274.x","article-title":"Autoimmune pulmonary alveolar proteinosis: treatment options in year 2013","volume":"18","author":"Leth","year":"2013","journal-title":"Respirology"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib92","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1525-139X.2011.01022.x","article-title":"Therapeutic apheresis for renal disorders","volume":"25","author":"Sanchez","year":"2012","journal-title":"Semin Dial"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib93","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000361014","article-title":"Immunoadsorption: a new strategy to induce remission in membranous lupus nephritis","volume":"4","author":"Ulinski","year":"2014","journal-title":"Case Rep Nephrol Urol"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib94","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1191\/0961203304lu489cr","article-title":"Cerebral vasculitis in a patient with hereditary complete C4 deficiency and systemic lupus erythematosus","volume":"13","author":"Lhotta","year":"2004","journal-title":"Lupus"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib95","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1093\/ndt\/6.8.536","article-title":"Treatment of rapidly progressive glomerulonephritis by extracorporeal immunoadsorption, prednisolone and cyclophosphamide","volume":"6","author":"Palmer","year":"1991","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib96","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1136\/ard.2005.043026","article-title":"Immunoadsorption and CD20 antibody treatment in a patient with treatment resistant systemic lupus erythematosus and preterminal renal insufficiency","volume":"65","author":"Rech","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib97","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/j.1442-200X.2007.02452.x","article-title":"Immunoadsorbent apheresis eliminates pathogenic IgG in childhood lupus nephritis","volume":"49","author":"Takahashi","year":"2007","journal-title":"Pediatr Int"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib98","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2165\/00063030-200519020-00004","article-title":"Cyclophosphamide and immunoadsorption apheresis treatment of lupus nephritis nonresponsive to drug therapy alone","volume":"19","author":"Stefanutti","year":"2005","journal-title":"BioDrugs"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib99","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1046\/j.1526-0968.2002.00408.x","article-title":"Dextran sulfate (Selesorb) plasma apheresis improves vascular changes in systemic lupus erythematosus","volume":"6","author":"Braun","year":"2002","journal-title":"Ther Apher"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib100","first-page":"545","article-title":"Selective removal of anti-DNA and anticardiolipin antibodies by adsorbent plasmapheresis using dextran sulfate columns in patients with systemic lupus erythematosus","volume":"18","author":"Hashimoto","year":"1991","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib101","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1007\/s10067-016-3354-2","article-title":"Rapid reduction of antibodies and improvement of disease activity by immunoadsorption in Chinese patients with severe systemic lupus erythematosus","volume":"35","author":"Huang","year":"2016","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.semnephrol.2017.05.020_bib102","first-page":"900","article-title":"Immunoadsorbent plasma perfusion in patients with systemic lupus erythematosus","volume":"17","author":"Schneider","year":"1990","journal-title":"J Rheumatol"}],"container-title":["Seminars in Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929517300591?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929517300591?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T04:47:44Z","timestamp":1750826864000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0270929517300591"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":102,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S0270929517300591"],"URL":"https:\/\/doi.org\/10.1016\/j.semnephrol.2017.05.020","relation":{},"ISSN":["0270-9295"],"issn-type":[{"value":"0270-9295","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunoadsorption in Autoimmune Diseases Affecting the Kidney","name":"articletitle","label":"Article Title"},{"value":"Seminars in Nephrology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semnephrol.2017.05.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}